2019-06 TRISCEND Study


I'm Interested

Trial ID: NCT04221490


Prospective, multi-center study to assess safety and performance of the Edwards EVOQUE Tricuspid Valve Replacement System

Official Title

Edwards EVOQUE Tricuspid Valve Replacement: Investigation of Safety and Clinical Efficacy After Replacement of Tricuspid Valve With Transcatheter Device

Stanford Investigator(s)

Rahul P Sharma, MBBS, FRACP
Rahul P Sharma, MBBS, FRACP

Clinical Associate Professor, Medicine - Cardiovascular Medicine

Christiane Haeffele
Christiane Haeffele

Clinical Associate Professor, Medicine - Cardiovascular Medicine Clinical Assistant Professor, Pediatrics - Cardiology

Jack Boyd
Jack Boyd

Clinical Associate Professor, Cardiothoracic Surgery

Mirela Tuzovic

Clinical Assistant Professor, Medicine - Cardiovascular Medicine

John W. MacArthur
John W. MacArthur

Assistant Professor of Cardiothoracic Surgery (Adult Cardiac Surgery)

David Lee, MD
David Lee, MD

Professor of Medicine (Cardiovascular Medicine)

Dominik Fleischmann
Dominik Fleischmann

Professor of Radiology (Cardiovascular Imaging)


Key Inclusion Criteria:

   - Functional or degenerative TR moderate or greater

   - Symptomatic despite medical therapy or prior HF hospitalization from TR

   - The Local Site Heart Team determines that the patient is appropriate for transcatheter
   tricuspid valve replacement

Key Exclusion Criteria:

   - Tricuspid valve anatomic contraindications

   - Need for emergent or urgent surgery or any planned cardiac surgery within the next 12

   - Hemodynamic instability

   - Refractory heart failure requiring advanced intervention

   - Currently participating in another investigational study in which the patient has not
   reached a primary endpoint


device: Transcatheter Tricuspid Valve Replacement


I'm Interested

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Research Nurse